Publikation

Natalizumab is effective as second line therapy in the treatment of relapsing remitting multiple sclerosis

Wissenschaftlicher Artikel/Review - 01.03.2009

Putzki Norman, Kollia K, Woods S, Igwe E, Diener H C, Limmroth V